Prognostic value of initial antithrombin levels in neonatal sepsis

Department of Pediatrics, Celal Bayar University, School of Medicine, Manisa, Turkey.
Indian pediatrics (Impact Factor: 1.04). 09/2007; 44(8):581-4.
Source: PubMed


We determined whether initial antithrombin (AT) levels help in diagnosis and prognosis of neonatal sepsis.
Sepsis was diagnosed according to clinical and laboratory findings and positive culture results in 34 of the 54 newborns who presented to the hospital with suspected sepsis. Between AT levels and hematological parameters (fibrinogen levels, prothrombin time (PT), activated partial thromboplastin time (aPTT) and liver function tests), these were correlated each other and with outcome of the babies.
Initial AT and fibrinogen levels were significantly lower in newborns with sepsis compared to control (P < 0.05). Initial AT levels were lower in the ones who developed disseminated intravascular coagulation (DIC) compared to those without DIC (P < 0.05). Initial AT levels were significantly lower in newborns who died as compared to survivors (P < 0.05). Sensitivity of AT was highest at 15 mg/dL for prognosis in neonatal sepsis (sensitivity:92.3%, specificity:61.9%, positive predictive value : 61.9 %; negative predictive value: 61.9%;).
Lower initial AT levels in neonatal sepsis are associated with a severe disease and increased mortality. It may be useful in predicting clinical outcome in neonatal sepsis.

16 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: The present review examines the major developments in early detection of neonatal sepsis, with an emphasis on the utility of diagnostic laboratory markers in clinical practice. Measures of acute phase proteins, cytokines, cell surface antigens, and bacterial genomes have been used alone or in combination to improve diagnosis of neonatal sepsis. Most studies evaluating laboratory diagnostic markers are retrospective cohorts or single center experience with relatively small sample size. Interpretation of these studies is confounded by inconsistent definitions of sepsis, heterogeneous sample populations, and different thresholds for diagnostic markers. Furthermore, many diagnostic markers are not available for routine care, they require specialized analytical procedures, and are expensive to perform. A better understanding of the neonatal inflammatory response to sepsis and identification of sensitive and specific markers of inflammation or rapid microbe-specific diagnostic tests would assist in the early detection of neonatal sepsis and in safely withholding antibiotics for patients in whom sepsis is unlikely.
    Current Opinion in Infectious Diseases 07/2008; 21(3):223-7. DOI:10.1097/QCO.0b013e3282fa15dd · 5.01 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Coagulopathy is a potentially underrecognized complication of sepsis and septic shock in critically ill neonatal foals. Critically ill neonatal foals have abnormalities in coagulation that are associated with disease severity and outcome. Foals <72 hours old admitted to a neonatal intensive care unit. Prospective, observational study. Blood was collected at admission, 24, and 48 hours for platelet count, prothrombin time, activated partial thromboplastin time, antithrombin activity and concentrations of fibrin degradation products, and fibrinogen in plasma from all foals. Sixty-three foals were enrolled and classified as Septic Shock (12), Septic (28), and Other (23). At least 1 abnormal value was found in 18/28 (64%) samples from the Septic Shock group, 66/85 (78%) from the Septic group, and 30/59 (51%) from the Other group (P= .01). Coagulopathy (3 or more abnormal values) was present in 7/28 (25%) samples in the Septic Shock group, 14/85 (16%) samples in the Septic group, and 3/59 (5%) samples in the Other group (P= .0028). Clinically detectable bleeding occurred in 8/12 (67%) Septic Shock cases, 11/28 (39%) Septic cases, and 3/23 (13%) Other cases (P= .009). Foals in Septic Shock were 12.7 times more likely to have clinical evidence of bleeding than those in the Other group (95% CI 2.3-70, P= .004). Treatment with fluids or plasma did not have a detectable effect on coagulation values. Coagulopathy commonly occurs in critically ill neonatal foals, especially those with sepsis and septic shock.
    Journal of Veterinary Internal Medicine 12/2008; 23(1):161-7. DOI:10.1111/j.1939-1676.2008.0229.x · 1.88 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The diagnosis of disseminated intravascular coagulation (DIC) relies on clinical signs and symptoms, identification of the underlying disease, the results of laboratory testing, and differentiation from other pathologies. The clinical features mainly depend on the underlying cause of the DIC. The laboratory diagnosis of DIC uses a combination of tests because no single test result alone can firmly establish or rule out the diagnosis. Global tests of hemostasis may initially provide evidence of coagulation activation and later in the process provide evidence of consumption of coagulation factors, but their individual diagnostic efficiency is limited. Fibrinolytic markers, in particular D-dimer, are reflective of activation of both coagulation and fibrinolysis, so that a normal finding can be useful for ruling-out DIC. Decreased levels of the natural anticoagulants (in particular, antithrombin and protein C) are frequently observed in patients with DIC, but their measurement is not normally incorporated into standard diagnostic algorithms. New tests are being explored for utility in DIC, and some additional tests may be useful on a case-by-case basis, depending on the proposed cause of the DIC or their local availability. For example, clot waveform analysis is useful but currently limited to a single instrument. Also, procalcitonin is an inflammatory biomarker that may be useful within the context of septic DIC, and activated factor X clotting time is an emerging test of procoagulant phospholipids that also seems to hold promise in DIC.
    Seminars in Thrombosis and Hemostasis 06/2010; 36(4):458-67. DOI:10.1055/s-0030-1254055 · 3.88 Impact Factor
Show more

Similar Publications


16 Reads
Available from